Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T18:09:47.122Z.
Calculation as of: 2026-10-06T18:09:47.122Z.
Quote observation: 2026-10-06T18:05:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 45d134847f39473b2f97a1bdf9e3b5a73b5de1aeed529bde146b49b76ed1db6a
PEG RATIO
N/A
Market Cap
$219.20M
PEG Ratio
N/A
TTM Avg
0.19
3Y Avg
1.29
5Y Avg
1.29
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Suja Life, Inc. (SUJA) | $235.03M | N/A | N/A | N/A | N/A |
| Limoneira Company (LMNR)vs › | $221.03M | N/A | 1.96 | 1.62 | 2.11 |
| Nature's Sunshine Products, Inc. (NATR)vs › | $219.20M | N/A | 0.19 | 1.29 | 1.29 |
| MGP Ingredients, Inc. (MGPI)vs › | $279.23M | N/A | 0.89 | 1.12 | 1.45 |
| Alico, Inc. (ALCO)vs › | $284.18M | N/A | 0.16 | 0.38 | 0.38 |
| CHS Inc. (CHSCM)vs › | $300.30M | N/A | N/A | N/A | N/A |
| CHS Inc. (CHSCN)vs › | $302.55M | N/A | N/A | N/A | N/A |
| CHS Inc. (CHSCP)vs › | $304.87M | N/A | N/A | N/A | N/A |
| CHS Inc. (CHSCL)vs › | $308.64M | N/A | N/A | N/A | N/A |
| CHS Inc. (CHSCO)vs › | $309.29M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
